voriconazole (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the voriconazole drug offered from Glenmark Pharmaceuticals Inc., USA. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
| NON-PROPRIETARY NAME: | voriconazole |
| SUBSTANCE NAME: | VORICONAZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-09-04 |
| END MARKETING DATE: | 0000-00-00 |
voriconazole HUMAN PRESCRIPTION DRUG Details:
| Item Description | voriconazole from Glenmark Pharmaceuticals Inc., USA |
| LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2015-09-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68462-572_8e2cd0de-c986-4db8-98f1-667222e45670 |
| PRODUCT NDC: | 68462-572 |
| APPLICATION NUMBER: | ANDA203503 |
Other VORICONAZOLE Pharmaceutical Manufacturers / Labelers:
